3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplastic Processes
1
Myeloproliferative Disorders
1
Leukemia
1
Hematologic Diseases
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Trastuzumab
9
Capecitabine
7
trastuzumab deruxtecan
6
Paclitaxel
6
Fulvestrant
6
pertuzumab
5
eribulin
5
Gemcitabine
4
Cyclophosphamide
4
sacituzumab govitecan
3
Vinorelbine
3
Doxorubicin
3
Docetaxel
3
Ado-Trastuzumab Emtansine
3
130-nm albumin-bound paclitaxel
3
selpercatinib
2
ribociclib
2
palbociclib
2
olaparib
2
larotrectinib
2
exemestane
2
abemaciclib
2
Fluorouracil
2
Epirubicin
2
Carboplatin
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
taxane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Breast Neoplasms
×
nilotinib
×
Clear all
No trials found.